Stock EXAS EXACT SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Exact Sciences Corporation

Equities

EXAS

US30063P1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
45.45 USD +0.44% Intraday chart for Exact Sciences Corporation -8.81% -38.56%
May. 24 Sector Update: Health Care Stocks Advance Pre-Bell Friday MT
May. 24 Exact Sciences to Present New Data at Oncology Annual Meeting Confirming Prognostic Value of Breast Cancer Test MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Exact Sciences to Participate in June Investor Conferences
BU
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
BU
Exact Sciences Earns 2024 Great Place to Work Certification
AQ
Exact Sciences Earns 2024 Great Place To Work® Certification™
BU
Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
BU
Exact Sciences : TCFD Report for the FY ended 12/29/2021
PU
Foundation Fighting Blindness Partners with PreventionGenetics and InformedDNA to Advance My Retina Tracker Genetic Testing Program
AQ
Exact Sciences : Names Aaron Bloomer as New Chief Financial Officer
PU
Exact Sciences: Q1 Earnings Snapshot
AQ
Exact Sciences Announces First-Quarter 2024 Results
BU
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
BU
Exact Sciences : ESG Report for the FY ended 12/31/2023
PU
Exact Sciences : SASB Index for the FY ended 12/30/2023
PU
Exact Sciences : TCFD Report for the FY ended 12/29/2023
PU
Exact Sciences to Participate in May Investor Conference
BU
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
BU
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
BU
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
BU
Exact Sciences Schedules First Quarter 2024 Earnings Call
BU
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. News Exact Sciences Corporation
  5. Press Releases